Diagnosis of Traumatic Carotid-Cavernous Sinus Fistula by Monitoring Venous Oxygen Saturation in the Jugular Bulb: Report of Two Cases

Autor: Massimo Rollo, Vittorio Mignani, Antonella Clemente, Francesco Della Corte

Publikováno v: Neurosurgery. 39:390-393

OBJECTIVE AND IMPORTANCE : A traumatic carotid-cavernous sinus fistula (CCF) is rarely diagnosed early and may sometimes be missed until clinical signs and symptoms appear. The continuous monitoring of cerebral venous oxygen saturation may reveal the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51a6c4ff00c64a324d3db6d48cdd95df
https://doi.org/10.1097/00006123-199608000-00033

A 1-year study to compare the efficacy and safety of once-daily travoprost 0.004%/timolol 0.5% to once-daily latanoprost 0.005%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension

Autor: Topouzis1, F., Melamed2, S., DANESH MEYER3, H., Wells4, A. P., Kozobolis5, V., Wieland6, H., Andrew6, R., Wells6, D., THE INTERNATIONAL TRAVOPROST/TIMOLOL STUDY GROUP University Hospital of Alexandroupolis, Ophthalmic, Department, Kozobolis*, Greece: Vassilios P., George, Maskaleris, Efstathios Detorakis, • II Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece: Fotis Topouzis, Eleftherios, Anastasopoulos, Theofanis Pappas, • Ophthalmiatrio Hospital of Athens, Greece: Artemios Kandarakis, John Koutroumanos, • Associate Professor of Ophthalmology, Eye Clinic of the General University Hospital of Ioannina, Greece: Miltiadis Aspiotis, Chrisavgi Pappa, • General Hospital of Nikaia 'AG, Panteleimon, Pireous, ', Greece: Emmanuel Vaikoussis, Thrassyvoulos, Paschalidis, Panagiotis, Bournas, Nikos Kazatzis, • Eye Associates, Sydney, Nsw, Australia: Ivan Goldberg, Stuart, Graham, Paul Healey, • Eye Surgery Associates, East Melbourne VIC, • Suite 8, Australia: Julian Lockhart Rait, Lindfield, Nsw, Australia: Allan Bank*, • Western Sydney Eye Hospital, University, Clinic, Westmead, Hospital, Westmead, Nsw, Healey*, Australia: Paul R., Jonathan, Crowston, Magdalena, Guzowski, Ranier, Covar, Anne, Lee, Jen, Wan, Domit Azar, • Quai des Tanneries 26, • Marktplatz 3, Belgium: Paul Stadion, Eupen, Belgium: François Lizin*, • University Hospital Antwerp, Service of Ophthalmology, Belgium: Veva De Groot, Patrick, Schraepen, Bruno Reyntjens, • University Hospital Ghent, Ghent, Belgium: Anna Maria Kestelyn Stevens, Fien Witters, • Department of Ophthalmology, University of Tartu, Estonia: Pait Teesalu, Imbi, Kuus, Maris Oll, • Ida Tallinna Keskhaigla Silmakliinik, Tallinn, Estonia: Ulle Aamer, Elo, Alas, Marko Pastak, • Hopital Jean Minjoz, Service, D’Ophtalmologie, Besancon, Cedex, Delbosc* • Augenarzt, France: Bernard Y. C., Goeppingen, Germany: Albrecht Gerstenberger*, • Augenarzt, Mannheim, Germany: Peter Jungmann*, • Facharzt fuer Augenheilkunde, Starnberg, Hamacher*, Germany: Ludwig T., Ursula Hellmair •, M. u. e. n. c. h. e. n. e. r. s. t. r. 3., Weilheim, Bayer*, Germany: Andreas U. M., Wolfgang Foerster, • Marktplatz 34 36, Schorndorf, Germany: Thomas Christ*, • Dipartimento di Specialità Medico Chirurgiche dell’Università di Catania, Marta, Azienda Ospedaliera '. S., Emanuele, V., Ferrarotto, Catania, ', Italy: Alfredo Reibaldi, Maurizio, Uva, Antonio, Longo, Daniela Lombardo, • Policlinico San Matteo, Clinica, Oculistica, Pavia, Italy: Fernando Trimarchi, Giovanni, Milano, Antonella, Clemente, Gemma Rossi, M., Ilaria, Scatassi, Francesca Montemurro, • Clinica Oculistica, Università di Torino, Grignolo, Federico, Beatrice, Brogliatti, Rolle, Teresa, Cristina, Favero, Elisabetta, Giacosa, Angela Fornero, • Goldschleger Eye Institute, Sheba Medical Center, Tel, Hashomer, Israel: Shlomo Melamed, Mordehai, Goldenfeld, Hani, Verbin, Zohar, Vilner, Ran, Knaan, Iris Moroz, • Department of Ophthalmology, Carmel Medical Center, Haifa, Israel: Orna Geyer, Eitan Segev, • Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Tel, Aviv, Israel: Shimon Kurtz, Meira, Neudorfer, Gabi, Shemesh, Shiri Zayit, • Glaucoma Service, Outpatient, Department, Clinical Hospital 'Gailezers, Riga, ', Latvia: Lasma Volksone, Lija Karlsone, • Department of Ophthalmology, Riga Stradins University Hospital, Riga, Latvia: Guna Laganovska, Kristine, Baumane, Ilze Egite, • Eye Clinic, Kaunas University of Medicine, Kaunas, Lithuania: Ingrida Januleviciene, Loreta Kuzmiene, • Eye Institute, Remuera, Auckland, New Zealand: Helen Danesh Meyer*, • Eye Department, Wellington, Hospital, Wellington, Wells*, New Zealand: Anthony P., Andrew, Riley, Anthony, Bedggood, Helen, Long, Nina Ashraff, • Hospital Sao Jose, Servico de Oftalmologia, Lisbon, Abrantes*, Portugal: Pedro A. L., Maria, Reina, Jose Pedro Silva, Joao Ilharco, • Department of Ophthalmology, National University Hospital, Singapore: Paul Tec Kwan Chew, Lennard, Thean, Lim Boon Ang, Joseph, Manuel, Loon Seng Chee, Clement, Tan, Yeong Suet Ming, • Singapore National Eye Centre, Singapore: Steve Kah Leng Seah, Francis, Oen, Rahat, Husain, Hoh Sek Tian, Aung Tin, • Hospital Clinico San Carlos, Madrid, Spain: Julián Garcia Sánchez, Julián García Feijoo, José María Martínez de La Casa, Alfredo Castillo Gómez, • Hospital Universitario Miguel Servet, Consulta de Ojos, Zaragoza, Spain: Francisco Manuel Honrubia López, Vicente Polo Llorens, Luis Pablo Júlvez, Maria Luisa Gómez Martínez, José Manuel Larrosa Póvez, • Fundación Hospital Alcorcón, Servicio de Oftalmología, Universidad Rey Juan Carlos, Alcorcon, Madrid, Spain: Alfonso Arias Puente, Carmen, Carrasco, Maria del Carmen, García, Yolanda, Andrés Alba, • Hospital Universitario La Princesa, Spain: Elena Gurdiel, Emilio, Dorronzoro, Maria Jesús Muniesa, • Department of Ophthalmology, Tri Service General Hospital, Taipei, Taiwan: Da Wen Lu*, • Consultant Ophthalmologist, Arrowe Park Hospital, Wirral, Merseyside, Clearkin*, UK: Louis G., Yogesh, Patwala

Publikováno v: European journal of ophthalmology. 17(2)

Purpose The objective of the study was to compare the intraocular pressure (IOP)-lowering efficacy and safety of travoprost 0.004%/timolol 0.5% ophthalmic solution (Trav/Tim) to latanoprost 0.005%/timolol 0.5% ophthalmic solution (Lat/Tim), dosed onc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a901fd82970319f519c647f684af0bc4
https://pubmed.ncbi.nlm.nih.gov/17415690